Voluntary Benefits Are Growing Fast. So Are the Lawsuits.

Accident, critical illness, and hospital indemnity products pay brokers 50–70% of premium in some cases. Plaintiffs' attorneys have noticed. ERISA class-action lawsuits filed as of 2026 are targeting exactly these three product categories. Your name might be on the plan document.

73% of employers added voluntary benefits to their 2024 packages, according to data cited by Optavise. That's rapid adoption. It's also outpacing employer due diligence by a wide margin.

The question isn't whether voluntary benefits have value. Some do. The question is who decided your employees needed these specific products, and what that person got paid to recommend them.

What's actually driving voluntary benefit growth?

Broker optimism about sales is part of it. According to the EBRI broker survey "Expanding the Benefits Horizon", 62% of brokers forecast growth in accident, critical illness, and hospital indemnity products. Those same brokers admit education gaps and administrative complexity are limiting employee value from those very products.

That tension matters. If brokers know employees aren't getting full value, and they're still projecting higher sales, something else is driving the recommendations.

Pet insurance was added by 27% of employer clients in 2025, up from 23% in 2024, per the Optavise 2025 Broker Report. Long-term care adoption jumped from 17% to 49% in a single year. One-year jumps like that don't come from sudden employee demand. They come from brokers with a product to push.

Why are ERISA lawsuits targeting these specific products?

Low loss ratios are the evidence. A low loss ratio means the carrier paid out a small fraction of premiums in actual claims. The rest went to overhead, profit, and commissions.

Holland & Knight's analysis of the new wave of ERISA litigation describes proposed class actions alleging brokers acted as functional ERISA fiduciaries. The claim is that brokers screened carrier bids and presented options that maximized broker commissions rather than employee value. That's a significant legal claim. It means the broker's recommendation wasn't neutral.

ERISA litigation risk analysis identifies low loss ratios as the primary evidentiary basis for plaintiffs' claims that voluntary benefit premiums were unreasonable. The products named include accident, critical illness, hospital indemnity, and cancer insurance. These aren't fringe products. They're the ones sitting in your open enrollment right now.

What's the employer's exposure here?

You're not just a bystander. Your company typically sponsors the platform that delivers these products to employees. Your name is on the administrative agreement. Your HR team conducted the enrollment.

If your broker recommended products with undisclosed commissions running 50–70% of premium, and those commissions were embedded in premiums your employees paid, you may have fiduciary exposure under ERISA. The Holland & Knight litigation overview makes clear that employer plan sponsors are named parties in these suits alongside brokers.

This connects directly to broker compensation disclosure. If you're not getting a full accounting of what your broker earns on every voluntary product, that's a gap you need to close before your next open enrollment. The 10 questions every CEO should ask a benefits consultant covers this ground directly.

Which voluntary benefits actually hold up under scrutiny?

The test is simple. Does the product pay claims in situations your employees will actually face, at a price that reflects what they're getting? Ask for the loss ratio before you add any product to your lineup.

Hospital indemnity can have genuine value for employees enrolled in high-deductible health plans. A hospitalization benefit that pays a flat cash amount helps cover the deductible gap. But the loss ratio still matters. If the carrier is paying 45 cents in claims for every dollar of premium, you're not offering a benefit. You're hosting a revenue stream for the carrier and your broker.

Critical illness has a narrower use case. The benefit triggers on a diagnosed condition, not on treatment costs. Employees with family history of covered conditions may value it. Employees without that context rarely use it. The education gap brokers themselves acknowledge makes it even less likely they'll file a claim correctly when they need to.

Accident insurance is the highest-volume product in this category and the most commonly cited in litigation. 49% of broker clients added it in 2025 per the Optavise 2025 Broker Report. That's a lot of premium flowing through a product with historically low loss ratios and high commissions.

What should you do before your next open enrollment?

Start by pulling the loss ratio for every voluntary product currently on your platform. Your broker should be able to get that from the carrier. If they can't, or won't, that tells you something.

Ask your broker to disclose, in writing, every dollar of compensation they receive from carriers for each voluntary benefit product you offer. This includes commissions, bonuses, and any override arrangements. The 10 questions every CEO should ask a benefits consultant covers this ground directly.

Then benchmark. A product with a 70%+ loss ratio and reasonable commissions is worth keeping. A product with a 40% loss ratio and a 60% commission is a problem. The Benefits Blueprint tool can help you structure that evaluation before open enrollment.

If your broker selected these products without showing you loss ratios or disclosing commissions, you have a real fiduciary conversation to start, not just a renewal conversation.

Frequently asked questions

What is a loss ratio and why does it matter for voluntary benefits?

A loss ratio is the percentage of premium dollars the carrier pays out in claims. If a carrier collects $1,000 in accident insurance premiums and pays $400 in claims, the loss ratio is 40%. A low loss ratio means employees are paying more than the benefit is worth. ERISA litigation filings identify low loss ratios as the primary evidence that voluntary benefit premiums were unreasonable. It's the first number you should request before adding any product.

Can my company be sued over voluntary benefits my broker recommended?

Yes. Proposed class-action lawsuits filed as of September 2026 name employer plan sponsors alongside brokers. If your company's benefit platform facilitated the sale of products with undisclosed, excessive commissions embedded in employee-paid premiums, plaintiffs' attorneys may argue you had a fiduciary duty to prevent that. Reviewing your ERISA fiduciary obligations before open enrollment is not optional at this point.

Are brokers required to disclose commissions on voluntary products?

Under CAA 2021 and ERISA Section 408(b)(2), brokers advising group health plans must disclose direct and indirect compensation. Voluntary benefit products sold through your employer platform often fall within that scope. Whether your broker has actually disclosed those commissions, in writing, for each product, is a different question. If you haven't received a written compensation disclosure, request one now using the guidance at broker compensation disclosure: do you get yours every year.

How do I know if a voluntary benefit is genuinely valuable for my employees?

Request the loss ratio. Ask for claims data on your specific group if you've offered the product for more than a year. Ask your broker to show you comparable products from at least two other carriers. Products with loss ratios above 65–70% and transparent commission structures are worth evaluating on their merits. Products below that threshold with undisclosed commissions above 30% deserve skepticism.

What's the fastest way to audit what I'm currently offering?

Pull your current voluntary benefit lineup. Ask your broker for the carrier name, annual premium volume, loss ratio, and broker compensation for each product. That's a four-column spreadsheet. A broker who can't produce all four columns within two weeks hasn't done the due diligence your employees deserved at enrollment.